Hims & Hers Super Bowl controversy: What the ad left out...

@LiveScience ha condiviso un link

2025-02-11 02:44:41 ·

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

www.livescience.com

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

0 Commenti ·0 condivisioni ·62 Views

Effettua l'accesso per mettere mi piace, condividere e commentare!

Passa a Pro

Scegli il piano più adatto a te

AGGIORNA